Aurealis Therapeutics AG Revenue and Competitors
Estimated Revenue & Valuation
- Aurealis Therapeutics AG's estimated annual revenue is currently $3.4M per year.
- Aurealis Therapeutics AG's estimated revenue per employee is $155,000
Employee Data
- Aurealis Therapeutics AG has 22 Employees.
- Aurealis Therapeutics AG grew their employee count by 0% last year.
Aurealis Therapeutics AG's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Head Pre-Clinical & Pharmacology | Reveal Email/Phone |
3 | Head Quality and Regulatory Affairs | Reveal Email/Phone |
4 | Director Microbiology, Genetic Engineering and Fermentation | Reveal Email/Phone |
5 | Chief Medical Officer | Reveal Email/Phone |
6 | Chief Operating Officer | Reveal Email/Phone |
7 | Clinical Project Manager | Reveal Email/Phone |
8 | Senior Clinical Project Manager | Reveal Email/Phone |
9 | Clinical Project Manager | Reveal Email/Phone |
Aurealis Therapeutics AG Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Aurealis Therapeutics AG?
Aurealis Therapeutics, a Swiss-Finnish private biopharmaceutical company, is now entering the clinical trial phase with its patented three-in-one combination product AUP-16 for chronic non-healing wounds and other regenerative diseases. The genetically modified lactic acid bacteria based therapy is designed to improve the quality of life for patients who requires tissue generation for example with diabetic foot ulcer. This is remarkable advancement for people who generally have only had access to medicines that treat symptoms versus promote tissue regeneration itself.
keywords:N/AN/A
Total Funding
22
Number of Employees
$3.4M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Aurealis Therapeutics AG News
The pipeline guide reviews pipeline therapeutics for Venous Leg Ulcers (Crural Ulcer) (Dermatology) by ... Aurealis Therapeutics AG.
Pfizer Inc. Sandoz Pharma Ltd. Biocon, Ltd. Fresenius Kabi AG · Aurobindo Pharma Limited · Zydus Cadila · Aurealis Therapeutics · Xbiome Co.,...
Aurealis Therapeutics AG is a Swiss-Finnish private clinical stage synthetic biology company focusing on development of lactic acid bacteria...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.5M | 25 | 14% | N/A |
#2 | $5.3M | 30 | -23% | N/A |
#3 | N/A | 35 | 59% | N/A |
#4 | $8.4M | 39 | 0% | N/A |
#5 | $12.7M | 67 | 24% | N/A |